Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a registry record for a planned observational study with no results reported; recruitment has not yet begun, making it a prospective design specification only.
This is a completed Phase 2 pilot study with very small enrollment (n=5) assessing only safety and tolerability of fisetin; no efficacy results are reported in this registry record.
Phase 1 safety trial in a special population (MCI patients) with no results yet reported; designed to evaluate tolerability and collect preliminary cognitive and biomarker data over 12 weeks.